Brief: Steven Cohen Reports 5.2% Passive Stake In Arcutis Biotherapeutics As Of Jan 30, 2024 - SEC Filing
31/01/2024 23:04
Jan 31 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O :
* STEVEN COHEN REPORTS 5.2% PASSIVE STAKE IN ARCUTIS
BIOTHERAPEUTICS INC AS OF JAN 30, 2024 - SEC FILING
Source text for Eikon: ID:n0000902664-24-000842
Further company coverage: ARQT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Canada Przoryve Cream 0.05% Receives Health Canada Approval For Atopic Dermatitis
Arcutis Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Arcutis Q2 revenue rises on demand for ZORYVE, lifts 2026 sales outlook
Arcutis Biotherapeutics Inc expected to post earnings of 4 cents a share - Earnings Preview
Brief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4